Should You Hold Sellas Life Sciences Group Inc (SLS) Stock Tuesday Morning?

Sellas Life Sciences Group Inc (SLS) has fallen Tuesday morning, with the stock losing -3.45% in pre-market trading to 1.12. SLS's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 132 out of 146 industries, the stock ranks higher than 63% of stocks. Sellas Life Sciences Group Inc has fallen 29.27% over the past month, closing at $1.47 on October 3. During this period of time, the stock fell as low as $0.90 and as high as $1.58. SLS has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

SLS has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on SLS!

See Full SLS Report

Sellas Life Sciences Group Inc has a Long-Term Technical rank of 9. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 91% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, SLS ranks better than 130% of stocks.

Important Dates for Investors in SLS:

-Sellas Life Sciences Group Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $-1.45. -We do not have a set dividend date for Sellas Life Sciences Group Inc at this time. Click Here To Get The Full Report on Sellas Life Sciences Group Inc (SLS)